ADENOSINE A2A RECEPTOR ANTAGONISTS

摘要

Disclosed herein are compounds having the structural formula (A) including pharmaceutically acceptable salts or solvates of said compound, wherein X, Y , Q and R are as defined in the specification; pharmaceutical compositions thereof; methods of treating central nervous system diseases by administerin g the compound of the present invention to a patient in need of such treatment , and processes for preparing the compound of this invention.